6505--Alendronate Tablets

Closed Pre-Solicitation Posted

This opportunity was awarded. See the award notice from , or the latest solicitation from .

Solicitation number
36E79725R0069
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The VA National Acquisition Center is procuring Alendronate Tablets for use by the Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service through an unrestricted competitive procurement under Request for Proposal 36E79725R0069. Offerors must provide the exact drug name as it appears on the label and include a unique NDC/UPC number, with packaging available in blister packs or unit of use bottles. The VA will award a single contract to the responsible offeror capable of providing an uninterrupted source of supply, with items distributed through the VA's Pharmaceutical Prime Vendor Programs. The solicitation will be issued in commercial item format in accordance with FAR Part 12 on October 28, 2025, with a tentative closing date of November 13, 2025. Interested offerors should monitor www.beta.sam.gov for any solicitation amendments and should direct questions to Contract Specialist Michael Olszewski at Michael.Olszewski@va.gov.

This procurement includes no set-aside designations and is open to all responsible sources. The contract structure consists of a one-year base period with four pre-priced one-year option periods, providing a potential five-year contract duration. The solicitation covers four specific Alendronate tablet configurations: 35mg tablets in both 4-count and 12-count packages, and 70mg tablets in both 4-count and 12-count packages, with total estimated annual usage ranging from 5,354 to 100,609 packages across these configurations. No incumbent information or specific budget ranges are disclosed in this pre-solicitation notice. The NAICS code assigned to this procurement is 325412, reflecting pharmaceutical preparation manufacturing.

Notice text

Presolicitation Notice

Page 1 of

Presolicitation Notice

Page 1 of 3

Presolicitation Notice

*=Required Field

Presolicitation Notice

Page 4 of 4

DESCRIPTION

Presolicitation Notice

Presolicitation Notice

Page 3 of 3

Page 1 of 4

Page 1 of 4

Presolicitation Notice

*=Required Field

Presolicitation Notice

Page 1 of 3

Page 1 of

Page 1 of

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0069 for an unrestrictive procurement for Alendronate Tablets for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC/UPC number. The standard package is a blister pack, but VA will accept unit of use bottles. Solicitation #36E79725R0069 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 28, 2025, with a tentative closing date of November 13, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.beta.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to: Michael.Olszewski@va.gov.

The estimated annual requirements are as follows:

ITEM

DESCRIPTION

PACKAGE SIZE (BOTTLES/BLISTER PACKS)

TOTAL

ESTIMATED

ANNUAL

USAGE

(BOTTLES/BLISTER PACKS)

1

ALENDRONATE 35MG TAB

4

21,300

2

ALENDRONATE 35MG TAB

12

5,354

3

ALENDRONATE 70MG TAB

4

80,074

4

ALENDRONATE 70MG TAB

12

100,609

Files

File Type Posted
36E79725R0069.docx DOCX document

Notice history

Notice Type Posted
6505--Alendronate Tablets Effective 05/21/2026 - 05/20/2027 Award Award Notice
6505--Alendronate Tablets Latest solicitation Solicitation
This notice Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America NAICS 325412 National Acquisition Center No set-aside
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity